NASDAQ
WOK
Last Price
US $1.98
KEY FIGURES
MKT CAP
$4.8M
EPS
TTM
$-10.35
PEG
TTM
-
P/E
TTM
N/M
P/S
TTM
0.02x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
WORK Medical Technology Group Ltd. Class A cash flow to debt ratio of 96.84% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial stability - Healthy cash flow growth.
WORK Medical Technology Group Ltd. Class A's free cash flow has increased -142.76% from $-11.49M last year to $4.91M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
WORK Medical Technology Group Ltd. Class A's debt to equity ratio is 0.35, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
WORK Medical Technology Group Ltd. Class A's debt has decreased relative to shareholder equity from 1.02 last year to 0.35 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
WORK Medical Technology Group Ltd. Class A has a net debt to EBITDA ratio of 6.95x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial risk - ICR.
WORK Medical Technology Group Ltd. Class A's interest coverage ratio is -4.96, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
WORK Medical Technology Group Ltd. Class A's profit margin has increased (-64.12%) in the last year from -30.35% to -10.89%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
WORK Medical Technology Group Ltd. Class A's short-term assets of $20.46M exceed its short-term liabilities of $11.97M
Decreasing performance - ROA.
WORK Medical Technology Group Ltd. Class A's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
WORK Medical Technology Group Ltd. Class A's return on equity of -6.86%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
WORK Medical Technology Group Ltd. Class A's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
WORK Medical Technology Group Ltd. Class A had positive net income in 3.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
WORK Medical Technology Group Ltd. Class A has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
WORK Medical Technology Group Ltd. Class A has a free cash flow yield of 102.58%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
WORK Medical Technology Group Ltd. Class A's yearly earnings has increased -69.28% since last year from $-3.49M to $-1.07M, signaling increasing performance
Decreasing performance - Healthy revenue growth.
WORK Medical Technology Group Ltd. Class A's yearly revenue has decreased -14.41% since last year from $11.51M to $9.85M, signaling decreasing performance
Decreasing performance - ROIC.
ROIC -9.04% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
WORK Medical Technology Group Ltd. Class A's 3-year revenue CAGR of -20.65% is negative, indicating declining revenue over the past 3 years
Decreasing performance - Revenue consistency.
WORK Medical Technology Group Ltd. Class A had revenue growth in only 0.00 out of 5 years, indicating inconsistent revenue performance
Increasing performance - ROE consistency.
WORK Medical Technology Group Ltd. Class A had positive ROE in 3.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
WORK Medical Technology Group Ltd. Class A has insufficient data to evaluate this check.
Overvalued - Earnings yield.
WORK Medical Technology Group Ltd. Class A has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
WORK Medical Technology Group Ltd. Class A is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
WORK Medical Technology Group Ltd. Class A has an EV/EBITDA ratio of 21.06x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Overvalued - PEG ratio value.
WORK Medical Technology Group Ltd. Class A has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
WORK Medical Technology Group Ltd. Class A has a price-to-book ratio of 0.01x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
WORK Medical Technology Group Ltd. Class A has a price-to-sales ratio of 0.02x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-6.86%
Return on equity
ROIC: -9.04%
Valuation History
-0.22X
Price to Earnings
EV/EBITDA: -5.7X
Cash flow
Profit margin
-
(FY vs FY)
EBITDA Y/Y
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $1.98
—
Default assumptions
EBITDA Multiple
Fair Value
Market $1.98
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.